GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Depomed, Inc. (DEPO) [hlAlert]

Depomed, Inc. (Depomed) is a specialty pharmaceutical company focused on the development and commercialization of differentiated products that are based on oral drug delivery technologies. Depomed has developed two
commercial products: GLUMETZA (metformin hydrochloride extended release tablets), which is a once-daily treatment for adults with type 2 diabetes that it commercializes in the United States with Santarus, Inc. (Santarus). ProQuin XR (ciprofloxacin hydrochloride extended release tablets), which is a once-daily treatment for uncomplicated urinary tract infections that Depomed commercializes in the United States with Watson Pharma (Watson).
.
( Total: 9 Current Stock Recommendations )
Depomed, Inc.   (9)
Hold 44% Buy 56%
Related companies
China Biologic ...   (4)
Buy 100%
BioSpecifics ...   (5)
Buy 100%
PROLOR Biotech, Inc.   (5)
Buy 100%
Opko Health Inc   (2)
Buy 100%
Flamel Technologies ...   (8)
Buy 100%
Aeterna Zentaris, ...   (12)
Buy 100%
Lannett Co Inc   (4)
Buy 100%
Anika Therapeutics ...   (4)
Buy 100%
Emergent ...   (6)
Buy 100%
Insys Therapeutics ...   (4)
Buy 100%
Filter by Gains:   
  
Rating:
Hold DEPO

Rating:
Hold DEPO

Rating:
Buy DEPO
up 41.52 %

Rating:
Buy DEPO
up 41.59 %

Rating:
Hold DEPO
up 93.59 %

Rating:
Hold DEPO

Rating:
Hold DEPO

Rating:
Buy DEPO

Rating:
Buy DEPO
up 55.59 %

Rating:
Buy DEPO
up 93.59 %

Rating:
Hold DEPO
Depomed, Inc. (DEPO) downgraded to Neutral by ROTH Capital
Thursday,  Feb 13, 2014  8:25 AM ET

Rating:
Hold DEPO

Rating:
Buy DEPO
up 422.68 %

Rating:
Buy DEPO
up 423.63 %
Depomed, Inc. (DEPO) rated Buy with price target $10 by Auriga
Friday,  Sep 30, 2011  8:25 AM ET

Rating:
Hold DEPO
down 35.53 %
Depomed, Inc. (DEPO) downgraded to Neutral by Merriman
Thursday,  Feb 18, 2010  11:25 AM ET

Your Recent Stocks
SymbolLastChange
DEPO 16.77 down  -41.77 %

RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy